Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 1115418 BOSTON, MA
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$140,597
+$64,583 QoQ
Shares Held
13,493
+9.2% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 95 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority Sole 17% Shared 0% None 83%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. RNAC ranks #260 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 396,380 $196,893,837
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,794 $98,390,870
3 MRNA
Moderna, Inc.
 809,853 $56,714,005
4 ALNY
Alnylam Pharmaceuticals, Inc.
 165,579 $49,844,246
5 INCY
Incyte Corp
 428,533 $48,578,500
6 RVMD
Revolution Medicines, Inc.
 226,008 $42,326,778
7 ROIV
Roivant Sciences Ltd.
 1,178,789 $41,717,342
8 JAZZ
Jazz Pharmaceuticals plc
 163,018 $39,282,447

All Filings in RNAC

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $140,597 13,493
2026-03-31 $76,014 12,360
2025-12-31 $87,522 12,139
2025-09-30 $134,229 13,134
2025-06-30 $136,846 13,171
2025-03-31 $171,419 13,006
2024-12-31 $182,699 10,201
2024-09-30 $149,496 9,274
2024-06-30 $229,233 8,487
2024-03-31 $84,423 129,883
2023-12-31 $87,874 127,539
2023-09-30 $133,677 126,111
2023-06-30 $134,178 119,802
2022-03-31 $133,500 108,537
2021-12-31 $353,608 108,469
2021-09-30 $449,899 108,149
2021-06-30 $439,781 105,211
2021-03-31 $313,731 69,333
2020-12-31 $215,184 71,018
2020-09-30 $151,617 61,136
2020-06-30 $211,085 74,326